Literature DB >> 1629344

Circumsporozoite genotyping of global isolates of Plasmodium vivax from dried blood specimens.

K C Kain1, A E Brown, H K Webster, R A Wirtz, J S Keystone, M H Rodriguez, J Kinahan, M Rowland, D E Lanar.   

Abstract

The prevalence and global distribution of two circumsporozoite (CS) genotypes of Plasmodium vivax (VK210 and VK247) were determined by genetic analysis of isolates from 234 malaria-infected patients. Whole blood specimens were collected on filter paper from patients infected with malaria in Thailand, Mexico, Papua New Guinea, Peru, Afghanistan (Pakistan), India, and western Africa and from 50 asymptomatic smear-negative controls. Following extraction of DNA from the filter paper samples, the CS gene was amplified by the polymerase chain reaction and genotyped by using oligoprobes specific for the VK210 and VK247 repeat epitopes. The sensitivity of genotyping from a single blood dot was 95.2%. The VK247 CS genotype was identified in the blood of patients from all seven study areas and was the predominant form present in samples from Thailand (83%) and Papua New Guinea (90%). In contrast, VK247 DNA was present in only 9% of isolates from Mexico. Individuals infected with both genotypes simultaneously were identified in all study areas except Mexico and were particularly common in Thailand (58%) and Papua New Guinea (60%). These findings indicate that the VK247 genotype of P. vivax is widely distributed but that its prevalence varies geographically. In addition, we conclude that use of samples of whole blood on filter paper is a practical and sensitive method for determining the genotypes of large numbers of malaria isolates collected in field settings.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1629344      PMCID: PMC265394          DOI: 10.1128/jcm.30.7.1863-1866.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Safety and immunogenicity of a Plasmodium vivax sporozoite vaccine.

Authors:  D M Gordon; T M Cosgriff; I Schneider; G F Wasserman; W R Majarian; M R Hollingdale; J D Chulay
Journal:  Am J Trop Med Hyg       Date:  1990-06       Impact factor: 2.345

2.  Antigenic diversity in Thai Plasmodium vivax circumsporozoite proteins.

Authors:  D E Arnot; M J Stewart; J W Barnwell
Journal:  Mol Biochem Parasitol       Date:  1990-11       Impact factor: 1.759

3.  Malaria. Variation and vaccination.

Authors:  F E Cox
Journal:  Nature       Date:  1991-01-17       Impact factor: 49.962

4.  Global distribution of a variant of the circumsporozoite gene of Plasmodium vivax.

Authors:  K C Kain; J Keystone; E D Franke; D E Lanar
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

5.  Circumsporozoite protein heterogeneity in the human malaria parasite Plasmodium vivax.

Authors:  R Rosenberg; R A Wirtz; D E Lanar; J Sattabongkot; T Hall; A P Waters; C Prasittisuk
Journal:  Science       Date:  1989-09-01       Impact factor: 47.728

6.  Widespread reactivity of human sera with a variant repeat of the circumsporozoite protein of Plasmodium vivax.

Authors:  A H Cochrane; E H Nardin; M de Arruda; M Maracic; P Clavijo; W E Collins; R S Nussenzweig
Journal:  Am J Trop Med Hyg       Date:  1990-11       Impact factor: 2.345

7.  Wide distribution of the variant form of the human malaria parasite Plasmodium vivax.

Authors:  S H Qari; I F Goldman; M M Povoa; S Oliveira; M P Alpers; A A Lal
Journal:  J Biol Chem       Date:  1991-09-05       Impact factor: 5.157

8.  Use of dried blood spot specimens in the detection of human immunodeficiency virus type 1 by the polymerase chain reaction.

Authors:  S Cassol; T Salas; M Arella; P Neumann; M T Schechter; M O'Shaughnessy
Journal:  J Clin Microbiol       Date:  1991-04       Impact factor: 5.948

9.  Determination of genetic variation within Plasmodium falciparum by using enzymatically amplified DNA from filter paper disks impregnated with whole blood.

Authors:  K C Kain; D E Lanar
Journal:  J Clin Microbiol       Date:  1991-06       Impact factor: 5.948

10.  Characteristics of natural antibody responses to the circumsporozoite protein of Plasmodium vivax.

Authors:  A E Brown; H K Webster; K Krinchai; D M Gordon; R A Wirtz; B Permpanich
Journal:  Am J Trop Med Hyg       Date:  1991-01       Impact factor: 2.345

View more
  27 in total

1.  Differential susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to infections with coindigenous Plasmodium vivax variants VK210 and VK247 in southern Mexico.

Authors:  L Gonzalez-Ceron; M H Rodriguez; J C Nettel; C Villarreal; K C Kain; J E Hernandez
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

2.  Molecular cloning and expression of the VK247 circumsporozoite protein for serodiagnosis of variant form Plasmodium vivax.

Authors:  Tong-Soo Kim; Hyung-Hwan Kim; Sun-Sim Lee; Chang-Mi Oh; Kyung-Mi Choi; Khin Lin; Jung-Yeon Kim; Byoung-Kuk Na; Eun-Taek Han; Youngjoo Sohn; Hyuck Kim; Hyeong-Woo Lee
Journal:  Parasitol Res       Date:  2011-02-12       Impact factor: 2.289

3.  High-throughput molecular diagnosis of circumsporozoite variants VK210 and VK247 detects complex Plasmodium vivax infections in malaria endemic populations in Papua New Guinea.

Authors:  Cara N Henry-Halldin; Daphne Sepe; Melinda Susapu; David T McNamara; Moses Bockarie; Christopher L King; Peter A Zimmerman
Journal:  Infect Genet Evol       Date:  2010-12-13       Impact factor: 3.342

4.  Plasmodium vivax: recent world expansion and genetic identity to Plasmodium simium.

Authors:  Chae Seung Lim; Loubna Tazi; Francisco J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-14       Impact factor: 11.205

5.  Plasmodium vivax circumsporozoite genotypes: a limited variation or new subspecies with major biological consequences?

Authors:  Wanessa C Souza-Neiras; Luciane M Storti-Melo; Gustavo C Cassiano; Vanja S C A Couto; Alvaro A R A Couto; Irene S Soares; Luzia H Carvalho; Maristela G Cunha; Marinete M Póvoa; Socrates Herrera; Myriam A Herrera; Andrea R M Rossit; Claudia M A Carareto; Ricardo L D Machado
Journal:  Malar J       Date:  2010-06-23       Impact factor: 2.979

6.  Prevalence of Plasmodium vivax VK210 and VK247 subtype in Myanmar.

Authors:  Tong-Soo Kim; Hyung-Hwan Kim; Sun-Sim Lee; Byoung-Kuk Na; Khin Lin; Shin-Hyeong Cho; Yoon-Joong Kang; Do-Kyung Kim; Youngjoo Sohn; Hyuck Kim; Hyeong-Woo Lee
Journal:  Malar J       Date:  2010-07-09       Impact factor: 2.979

7.  Genetic variation among Plasmodium vivax isolates adapted to non-human primates and the implication for vaccine development.

Authors:  Francis B Ntumngia; Amy M McHenry; John W Barnwell; Jennifer Cole-Tobian; Christopher L King; John H Adams
Journal:  Am J Trop Med Hyg       Date:  2009-02       Impact factor: 2.345

8.  Genetic diversity of Plasmodium vivax clinical isolates from southern Pakistan using pvcsp and pvmsp1 genetic markers.

Authors:  Afsheen Raza; Najia K Ghanchi; Ali M Thaver; Sana Jafri; Mohammad A Beg
Journal:  Malar J       Date:  2013-01-11       Impact factor: 2.979

9.  Genetic diversity of Plasmodium vivax and Plasmodium falciparum in Honduras.

Authors:  Ana Cecilia Lopez; Andres Ortiz; Jorge Coello; Wilfredo Sosa-Ochoa; Rosa E Mejia Torres; Engels I Banegas; Irina Jovel; Gustavo A Fontecha
Journal:  Malar J       Date:  2012-11-26       Impact factor: 2.979

10.  Molecular and epidemiological characterization of Plasmodium vivax recurrent infections in southern Mexico.

Authors:  Lilia Gonzalez-Ceron; Jianbing Mu; Frida Santillán; Deirdre Joy; Marco A Sandoval; Gerardo Camas; Xinzhuan Su; Elena V Choy; Rene Torreblanca
Journal:  Parasit Vectors       Date:  2013-04-18       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.